On mission to transform healthcare

Rogier Janssens shapes Merck's patient-centric strategy in China

Since getting appointed as managing director of Merck Biopharma China in August 2017, Rogier Janssens has crisscrossed Chinese cities on weekdays as well as over the weekends, to learn more about the local culture and healthcare systems.

That's because China is Merck's key market with increasing financial impact.